Picture of Abbott Laboratories logo

ABT Abbott Laboratories Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Abbott Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments4,1407,14810,24910,1707,279
Net Total Accounts Receivable
Net Total Receivables5,4256,4146,4876,2186,565
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets15,66720,44124,23925,22422,670
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment8,97210,13010,11210,27811,276
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets67,88772,54875,19674,43873,214
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities10,86311,90713,10515,48913,841
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities36,79939,76439,39437,75234,611
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity31,08832,78435,80236,68638,603
Total Liabilities & Shareholders' Equity67,88772,54875,19674,43873,214
Total Common Shares Outstanding